Registry following patients treated with stereotactic radiation for tumors and other conditions
Tracks patients receiving stereotactic radiation for tumors, brain vessel malformations, or nerve pain.
Key facts
- Who runs it
- The Radiosurgery Society
- Where
- Brunswick, Chattanooga, Colorado Springs, Danville, Detroit, Egg Harbor, Huntington, Miami, Philadelphia, Pottstown, Red Bank, The Bronx, and Toms River, United StatesSee the 13 sites
- Trial code
- Registry title
- RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
- Status
- Recruiting
- People taking part
- 50,000 people, planned
- Started
- Mar 2012
- Expected to end
- Dec 2030
- Type of study
- Observational
- Treatments tested
- SRS/SBRT
- Record updated
- 19 September 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The registry is looking for people with benign or malignant tumors or other conditions that doctors consider treatable with stereotactic radiosurgery (SRS) or stereotactic body radiotherapy (SBRT).
- Sex
- All sexes can join.
- Disease stage
- Benign or malignant tumors, or other conditions considered treatable by stereotactic radiosurgery or stereotactic body radiotherapy.
Main reasons for not taking part
- Not willing to sign the informed consent document or to agree verbally to take part
- Declines to take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy
- Willingness to sign an Informed Consent Document or verbally agree to participation
Who cannot take part
- There are no specific exclusion criteria, but patients who are unwilling to sign the ICD or who decline participation will not be included
Where in United States
- Southeast Georgia Health SystemBrunswick, United StatesContact: Jan Jenkins, RNEnrolling by invitation
- Cyberknife at ErlangerChattanooga, United StatesContact: Jan Jenkins, RNEnrolling by invitation
- Penrose Cancer CenterColorado Springs, United StatesContact: Jan Jenkins, RNEnrolling by invitation
- Geisinger Health SystemDanville, United StatesContact: Jan Jenkins, RNEnrolling by invitation
- Henry Ford Health SystemDetroit, United StatesContact: Celina Kirsch, P.A.Taking people
- AtlantiCare Regional Medical Center and AtlantiCare Cancer Care InstituteEgg Harbor, United StatesContact: Jan Jenkins, RNEnrolling by invitation
- St. Mary's Medical CenterHuntington, United StatesContact: Jan Jenkins, RNEnrolling by invitation
- Sylvester Comprehensive Cancer Center, University of MiamiMiami, United StatesContact: Gregory A Azzam, MDTaking people
- Philadelphia CyberKnifePhiladelphia, United StatesContact: Jan Jenkins, RNEnrolling by invitation
- Pottstown Memorial Medical CenterPottstown, United StatesContact: Jan Jenkins, RNEnrolling by invitation
- Riverview Medical CenterRed Bank, United StatesContact: Jan Jenkins, RNEnrolling by invitation
- Montefiore Medical CenterThe Bronx, United StatesContact: Jan Jenkins, RNEnrolling by invitation
- NJ Cyberknife at Community Medical CenterToms River, United StatesContact: Jan Jenkins, RNEnrolling by invitation
About the trial
What the trial wants to find out
The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases. (This study was formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a CyberKnife subset of RSSearch.)
The group in the trial
- Patients being treated by SRS/SBRT
Patients with a condition being considered for treatment by SRS/SBRT
Treatment: SRS/SBRT
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Multi-Institution Registry of SRS/SBRT Procedures
- Plain-language title
- Registry following patients treated with stereotactic radiation for tumors and other conditionsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch® Patient Registry.Radiation oncology (London, England), 2018
- Record updated
- 19 September 2024